Skip to content

A Brief Mindful Drinking/Eating Intervention for Hemodialysis Patients With Fluid Restrictions

A Brief Mindful Drinking/Eating Intervention for Hemodialysis Patients With Fluid Restrictions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04016311
Enrollment
38
Registered
2019-07-11
Start date
2019-06-25
Completion date
2020-05-07
Last updated
2021-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Restriction, Hemodialysis, Interdialytic Weight Gain, Kidney Failure, Mindfulness, Quality of Life

Brief summary

The purpose of this pilot study is to find out whether mindful drinking/eating activities can improve quality of life and help make it easier for people on dialysis to follow their fluid restrictions. The pilot study is a randomized controlled trial with an intervention group and a wait list control group, randomized by cohort days. The intervention occurs during dialysis sessions once a week for 4 weeks. During each intervention session, participants are guided through a mindful eating exercise focused on foods recommended for controlling thirst (e.g., hard candy, frozen grapes) and a mindful drinking exercise. Participants are asked to practice mindful drinking/eating at least once daily at home.

Interventions

BEHAVIORALMindful Drinking/Eating Intervention

Participants will be individually guided during their dialysis session through: 1) a mindful drinking exercise, a meditation focused on the sensory experience of 3 sips of fluid, along with a discussion of the experience; and 2) a mindful eating exercise with select foods that are recommended for controlling thirst (i.e., hard candy, frozen fruits). Participants will be given directions for mindful drinking/eating and asked to practice mindful drinking/eating as often as possible but least once each day.

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Intervention and wait list control groups with rolling admission.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Receiving hemodialysis * Able to speak English

Exclusion criteria

* Missed more than one dialysis treatment in the past month

Design outcomes

Primary

MeasureTime frameDescription
Total Score for Kidney-Disease Quality of Life Short Form v1.34 weeksTotal Score for Kidney-Disease Quality of Life Short Form v1.3 Higher scores indicate greater quality of life. Score range from 0 to 100
Interdialytic Weight Gain (IWG)4 weeksAverage of 3 Interdialytic Weight gain measures taken the week after last intervention section (4 week time frame). Interdialytic weight gain is calculated as the patients' weight at the beginning of each hemodialysis session (pre-weight) minus the weight after the previous hemodialysis session (post-weight). Measured in kilograms. Lower numbers are better. Proxy measure for adhering to fluid restriction.

Secondary

MeasureTime frameDescription
Mindful Eating4 weeksTotal score on Mindful Eating Questionnaire Total Scores range from 1 to 4. Higher scores indicate more mindful eating.

Countries

United States

Participant flow

Recruitment details

Recruited from 2 dialysis centers. Assigned randomly by cohort (Tues/Thurs/Sat dialysis patients vs Monday/Wed/Friday) to prevent contamination.

Participants by arm

ArmCount
Mindful Drinking/Eating Group
Mindful Drinking/Eating Intervention: Participants will be individually guided during their dialysis session through: 1) a mindful drinking exercise, a meditation focused on the sensory experience of 3 sips of fluid, along with a discussion of the experience; and 2) a mindful eating exercise with select foods that are recommended for controlling thirst (i.e., hard candy, frozen fruits). Participants will be given directions for mindful drinking/eating and asked to practice mindful drinking/eating as often as possible but least once each day.
18
Wait List Control
Usual treatment - offered intervention after completion of post-test data collection.
20
Total38

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicMindful Drinking/Eating GroupTotalWait List Control
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
9 Participants20 Participants11 Participants
Age, Categorical
Between 18 and 65 years
9 Participants18 Participants9 Participants
Age, Continuous61.56 years
STANDARD_DEVIATION 13.85
61.53 years
STANDARD_DEVIATION 14.51
61.50 years
STANDARD_DEVIATION 15.44
Ethnicity (NIH/OMB)
Hispanic or Latino
8 Participants18 Participants10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants19 Participants10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
1 Participants1 Participants0 Participants
Interdialytic Weight Gain2.46 kilograms
STANDARD_DEVIATION 1.1
2.49 kilograms
STANDARD_DEVIATION 1.07
2.52 kilograms
STANDARD_DEVIATION 1.1
Mindful Eating Questionnaire3.08 units on a scale
STANDARD_DEVIATION 0.32
3.00 units on a scale
STANDARD_DEVIATION 0.28
2.94 units on a scale
STANDARD_DEVIATION 0.23
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Black or African American
7 Participants13 Participants6 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants2 Participants0 Participants
Race (NIH/OMB)
White
9 Participants21 Participants12 Participants
Region of Enrollment
United States
18 participants38 participants20 participants
Sex: Female, Male
Female
5 Participants12 Participants7 Participants
Sex: Female, Male
Male
13 Participants26 Participants13 Participants
Total score Kidney Disease Quality of Life -36 SF68.64 units on a scale
STANDARD_DEVIATION 15.12
66.09 units on a scale
STANDARD_DEVIATION 14.99
63.92 units on a scale
STANDARD_DEVIATION 14.91

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 180 / 20
other
Total, other adverse events
0 / 180 / 20
serious
Total, serious adverse events
1 / 182 / 20

Outcome results

Primary

Interdialytic Weight Gain (IWG)

Average of 3 Interdialytic Weight gain measures taken the week after last intervention section (4 week time frame). Interdialytic weight gain is calculated as the patients' weight at the beginning of each hemodialysis session (pre-weight) minus the weight after the previous hemodialysis session (post-weight). Measured in kilograms. Lower numbers are better. Proxy measure for adhering to fluid restriction.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Mindful Drinking/Eating GroupInterdialytic Weight Gain (IWG)2.86 kilogramsStandard Deviation 1.51
Wait List ControlInterdialytic Weight Gain (IWG)2.46 kilogramsStandard Deviation 0.97
Primary

Total Score for Kidney-Disease Quality of Life Short Form v1.3

Total Score for Kidney-Disease Quality of Life Short Form v1.3 Higher scores indicate greater quality of life. Score range from 0 to 100

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Mindful Drinking/Eating GroupTotal Score for Kidney-Disease Quality of Life Short Form v1.369.66 score on a scaleStandard Deviation 15.79
Wait List ControlTotal Score for Kidney-Disease Quality of Life Short Form v1.366.12 score on a scaleStandard Deviation 13.24
Secondary

Mindful Eating

Total score on Mindful Eating Questionnaire Total Scores range from 1 to 4. Higher scores indicate more mindful eating.

Time frame: 4 weeks

ArmMeasureValue (MEAN)Dispersion
Mindful Drinking/Eating GroupMindful Eating3.12 score on a scaleStandard Deviation 0.26
Wait List ControlMindful Eating3.03 score on a scaleStandard Deviation 0.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026